-
公开(公告)号：US08927027B2
公开(公告)日：2015-01-06
申请号：US13132545
申请日：2009-12-02
申请人： Joseph Fournell , Scott Eaker , Scott Elster , David J. Rechtman
发明人： Joseph Fournell , Scott Eaker , Scott Elster , David J. Rechtman
CPC分类号： A23C9/206 , A23C3/02 , A23C9/1422 , A23C9/1427 , A23C9/148 , A23C9/1522 , A23C9/158 , A23L33/40 , A23V2002/00 , A61K35/20 , A23V2250/28 , A23V2200/3202
摘要： This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.
摘要翻译： 该公开内容特征在于人乳液渗透物和含有从分馏的全人乳中获得的组合物的组合物。 本发明的富含寡糖的渗透物和渗透物组合物可用作前期和全期婴儿的营养补充剂，用于建立或维持肠道菌群和治疗炎症性肠病的症状。
-
2.发明申请NUTRITIONAL COMPOSITIONS CONTAINING HUMAN MILK OLIGOSACCHARIDES AND METHODS FOR USING THE SAME 审中-公开含有人乳酪寡糖的营养组合物及其使用方法公开(公告)号：US20130059815A1
公开(公告)日：2013-03-07
申请号：US13605223
申请日：2012-09-06
申请人： Joseph FOURNELL , Scott Eaker , Scott Elster , David J. Rechtman
发明人： Joseph FOURNELL , Scott Eaker , Scott Elster , David J. Rechtman
CPC分类号： A23C9/206 , A23C3/02 , A23C9/1422 , A23C9/1427 , A23C9/148 , A23C9/1522 , A23C9/158 , A23L33/40 , A23V2002/00 , A61K35/20 , A23V2250/28 , A23V2200/3202
摘要： This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.
摘要翻译： 该公开内容特征在于人乳液渗透物和含有从分馏的全人乳中获得的组合物的组合物。 本发明的富含寡糖的渗透物和渗透物组合物可用作前期和全期婴儿的营养补充剂，用于建立或维持肠道菌群和治疗炎症性肠病的症状。
-
公开(公告)号：US20130059050A1
公开(公告)日：2013-03-07
申请号：US13566753
申请日：2012-08-03
申请人： Joseph Fournell , Scott Eaker , Armando Montoya
发明人： Joseph Fournell , Scott Eaker , Armando Montoya
摘要： The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
摘要翻译： 本发明涉及一种处理未加工的人乳以生产具有不可检测水平的细菌的经处理的人乳的方法。 将牛奶脱脂以产生脱脂人乳，然后进行微量过滤以产生具有不可检测水平的细菌（包括蜡状芽孢杆菌）的滤液。 所得到的人乳可以进一步加工，使用和/或出售。
-
公开(公告)号：US20080124430A1
公开(公告)日：2008-05-29
申请号：US11947580
申请日：2007-11-29
摘要： The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.
摘要翻译： 本发明的特征在于人乳强化剂组合物，标准化的人乳及其制备和使用方法。 在一个实施方案中，巴氏灭菌的人乳组合物包含约35-85mg / mL的人蛋白质成分; 约60-110mg / mL的人体脂肪成分; 和约60-140mg / mL的人类碳水化合物成分。
-
公开(公告)号：US10820604B2
公开(公告)日：2020-11-03
申请号：US13566753
申请日：2012-08-03
申请人： Joseph Fournell , Scott Eaker , Armando Montoya
发明人： Joseph Fournell , Scott Eaker , Armando Montoya
摘要： The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
-
公开(公告)号：US08545920B2
公开(公告)日：2013-10-01
申请号：US11947580
申请日：2007-11-29
摘要： The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.
摘要翻译： 本发明的特征在于人乳强化剂组合物，标准化的人乳及其制备和使用方法。 在一个实施方案中，巴氏灭菌的人乳组合物包含约35-85mg / mL的人蛋白质成分; 约60-110mg / mL的人体脂肪成分; 和约60-140mg / mL的人类碳水化合物成分。
-
公开(公告)号：US20110256233A1
公开(公告)日：2011-10-20
申请号：US13132545
申请日：2009-12-02
申请人： Joseph Fournell , Scott Eaker , Scott Elster , David J. Rechtman
发明人： Joseph Fournell , Scott Eaker , Scott Elster , David J. Rechtman
CPC分类号： A23C9/206 , A23C3/02 , A23C9/1422 , A23C9/1427 , A23C9/148 , A23C9/1522 , A23C9/158 , A23L33/40 , A23V2002/00 , A61K35/20 , A23V2250/28 , A23V2200/3202
摘要： This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.
摘要翻译： 该公开内容特征在于人乳液渗透物和含有从分馏的全人乳中获得的乳汁的组合物本发明的富含多糖的渗透物和渗透物组合物可用作前期和全期婴儿的营养补充剂，用于建立或维持肠道菌群和 治疗炎症性肠病的症状。
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.013 秒)
